Analyst Recommendations
53.16 0.39(0.74%)10/04/2024
Crinetics Pharmaceuticals Inc (CRNX)
Crinetics Pharmaceuticals Inc (CRNX)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 11 |
Overweight | 8 |
Market Outperform | 7 |
Outperform | 7 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades